SCHEMBL5873600

SCHEMBL5873600

CCOC(=O)C(C)=CC=CC(C)=CC=CC=C(C)C=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.49
ALDH1A1 P00352 7/20 0.42
HSD17B10 Q99714 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
ALOX15 P16050 2/20 0.42
RECQL P46063 2/20 0.42
TSHR P16473 1/20 0.42
GLO1 Q04760 1/20 0.41
MAPT P10636 4/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 1/20 0.34
LMNA P02545 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
PGR P06401 2/20 0.33
NR1I2 O75469 1/20 0.33
PTPN1 P18031 1/20 0.33
GAA P10253 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2616646 1.00 PTGS1 (0.49) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL11814497 0.93 GLO1 (0.46) PTGS1ALDH1A1HSD17B10ALOX15TSHR
SCHEMBL11814501 0.93 GLO1 (0.46) PTGS1ALDH1A1HSD17B10ALOX15TSHR
SCHEMBL5071853 0.93 PTGS1 (0.55) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL5071854 0.93 PTGS1 (0.55) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL2616636 0.87 PTGS1 (0.49) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL8505049 0.87 PTGS1 (0.68) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL8503596 0.87 PTGS1 (0.68) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL9716795 0.87 PTGS1 (0.43) PTGS1ALDH1A1HSD17B10TDP1ALOX15
SCHEMBL9689061 0.87 PTGS1 (0.43) PTGS1ALDH1A1HSD17B10TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121735813-A Synthesis method of beta-apo-8' -ethyl carotenoate 肇庆巨元生化有限公司 2026-03-27 CN disclosed
CN-121517340-A Preparation method of beta-apo-8' -ethyl carotenate 广州巨元生化有限公司 2026-02-13 CN disclosed
US-7045641-B2 Process for preparing polyenedialdehyde monoacetals BASF AKTIENGESELLSCHAFT (DE) 2006-05-16 US disclosed
US-20030158427-A1 Process for preparing polyenedialdehyde monoacetals BASF AKTIENGESELLSCHAFT (DE) 2003-08-21 US disclosed
EP-1325919-A1 Process for the preparation of polyendialdehydemonoacetals BASF AKTIENGESELLSCHAFT (DE) 2003-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158427-A1 Process for preparing polyenedialdehyde monoacetals PDHA2, AKR1C4, SRD5A2 PTGS1 184/4885ALDH1A1 49/4885HSD17B10 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.